Item 8.01 Other Events.

On May 3, 2023, Tengjun Biotechnology Corp. (the "Company") conducted its second and final closing of the public offering of its common stock pursuant to the Company's registration statement on Form S-1 (File No. 333-266300) initially filed with the Securities and Exchange Commission ("Commission") on July 22, 2022 and declared effective on November 4, 2022 (the "Registration Statement"), whereby the Company offered and sold additional 1,402,027 shares of common stock (the "Shares") at $1.00 per share for a total purchase price of $1,402,027 from the investors. Together with the 3,000,000 Shares issued and sold pursuant to the initial closing on January 9, 2023 raising $3,000,000, the Company offered and sold an aggregate of 4,402,027 shares of common stock for a total of $4,402,027 under the public offering pursuant to the Registration Statement as of May 3, 2023.





                                       1

© Edgar Online, source Glimpses